Momentus Inc. Announces First Quarter 2022 Financial Results
Momentus Inc. (NASDAQ: MNTS) reported its financial results for Q1 2022, revealing progress in launching its Vigoride spacecraft. The spacecraft is now at Cape Canaveral for integration with a SpaceX Falcon 9 rocket, with the launch targeted for this month. The company successfully conducted extensive ground tests and signed agreements for four additional SpaceX missions through 2023. Momentus has also secured requisite government licenses and approvals, bolstering its regulatory compliance. Key talent has been added to strengthen the team, enhancing its competitive edge in the aerospace sector.
- Successfully delivered Vigoride spacecraft to Cape Canaveral for upcoming launch.
- Conducted extensive ground tests on Vigoride, ensuring readiness for space conditions.
- Secured Launch Services Agreements for four additional SpaceX missions, enhancing future revenue streams.
- Obtained necessary government licenses and approvals, strengthening regulatory compliance.
- Added experienced leadership team, providing a competitive advantage in the space industry.
- None.
"We’re excited to have seen momentum building last quarter as we move toward the first launch of our Vigoride orbital transfer vehicle to low earth orbit," said
Rood went on to say, “We’re grateful for the cooperation and dedication shown by our
First Quarter 2022 Business Highlights:
- Completed a series of extensive ground tests on the Vigoride spacecraft targeted to launch this month. These tests included system-level thermal vacuum testing, which closely simulates the environment Vigoride will encounter in space, and vibration testing, which simulates the environment the spacecraft will encounter during launch.
-
Delivered the Vigoride 3 spacecraft to the launch site at
Cape Canaveral, Florida for integration on theSpaceX Falcon 9 launch vehicle. - Integrated customer satellites and an experimental customer payload onto the Vigoride spacecraft.
-
In addition to a port for the Vigoride orbital transfer vehicle,
Momentus purchased a second port on theSpaceX Transporter-5 mission to use a third-party deployer system to place other customer satellites in orbit. This is part of the Company’s effort to explore providing services as a ride share aggregator and deploying customer satellites that have less complex requirements at lower cost. -
Signed Launch Services Agreements for four additional
SpaceX missions including Transporter-6, targeted forOctober 2022 , Transporter-7, targeted forJanuary 2023 , Transporter-8, targeted forApril 2023 , and Transporter-9, targeted forOctober 2023 . -
Took substantial steps to address regulatory matters affecting the Company culminating in obtaining all the necessary government licenses and approvals for
Momentus to launch its first orbital transfer vehicle to space. This included:-
Continued implementation of our National Security Agreement (NSA) with the
U.S. Government , which is overseen by theDepartment of Defense andDepartment of the Treasury ; -
Approval of license updates from the
National Oceanic and Atmospheric Administration (NOAA) both during the quarter and after the close of the quarter; -
Obtaining a license from the
Federal Communications Commission (FCC) for our first Vigoride launch after the end of the quarter; and -
Approval of a favorable payload determination from the
Federal Aviation Administration (FAA) after the end of the quarter.
-
Continued implementation of our National Security Agreement (NSA) with the
-
Added key talent with impressive and long careers that will provide a competitive advantage. (This occurred during the quarter and after the end of the quarter). Key talent additions included:
-
Charles Chase , Vice President of Engineering; -
Nick Zello , Vice President of Manufacturing and Operations; -
Gary Bartmann , Vice President of Supply Chain; and -
Jason Garkey , Chief Security Officer.
-
“The caliber of the leaders we added recently is truly impressive,” said
Conference Call Information
About
Forward-Looking Statements
This press release contains certain statements which may constitute “forward-looking statements” within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include, but are not limited to, statements regarding
Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on our current beliefs, expectations and assumptions regarding the future of our business, future plans and strategies, projections, anticipated events and trends, the economy and other future conditions.
Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of Momentus’ control. Many factors could cause actual future events to differ materially from the forward-looking statements in this press release, including but not limited to: the ability of the Company to obtain licenses and government approvals for its missions, which are essential to its operations; the ability of the Company to effectively market and sell satellite transport services and planned in-orbit services; the ability of the Company to protect its intellectual property and trade secrets; the development of markets for satellite transport and in-orbit services; the ability of the Company to develop, test and validate its technology, including its water plasma propulsion technology; delays or impediments that the Company may face in the development, manufacture and deployment of next generation satellite transport systems; the ability of the Company to convert backlog or inbound inquiries into revenue; changes in applicable laws or regulations and extensive and evolving government regulations that impact operations and business, including export control license requirements; the ability to attract or maintain a qualified workforce with the required security clearances and requisite skills; product service or product or launch failures or delays that could lead customers to use competitors’ services; investigations, claims, disputes, enforcement actions, litigation and/or other regulatory or legal proceedings; the effects of the COVID-19 pandemic on the Company’s business; the Company’s ability to comply with the terms of its National Security Agreement and any related compliance measures instituted by the director who was approved by the CFIUS Monitoring Agencies (the “Security Director”); the possibility that the Company may be adversely affected by other economic, business, and/or competitive factors; and/or other risks and uncertainties. These are only some of the factors that may affect the forward-looking statements contained in this press release. For a discussion identifying additional important factors that could cause actual results to differ materially from those anticipated in the forward-looking statements, see the company’s filings with the
First Quarter 2022 Financial Results
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (in thousands, except share data) |
|||||||
|
Three Months Ended
|
||||||
|
|
2022 |
|
|
|
2021 |
|
Service revenue 1 |
$ |
— |
|
|
$ |
130 |
|
Cost of revenue 2 |
|
— |
|
|
|
48 |
|
Gross margin |
|
— |
|
|
|
82 |
|
Operating expenses: |
|
|
|
||||
Research and development expenses |
|
9,971 |
|
|
|
9,906 |
|
Selling, general and administrative expenses |
|
14,853 |
|
|
|
14,005 |
|
Total operating expenses |
|
24,824 |
|
|
|
23,911 |
|
Loss from operations |
|
(24,824 |
) |
|
|
(23,829 |
) |
|
|
|
|
||||
Other income (expense): |
|
|
|
||||
Decrease (increase) in fair value of SAFE notes |
|
— |
|
|
|
81,564 |
|
Decrease (increase) in fair value of warrants |
|
(451 |
) |
|
|
8,083 |
|
Realized loss on disposal of asset |
|
(70 |
) |
|
|
— |
|
Interest income |
|
— |
|
|
|
1 |
|
Interest expense |
|
(1,492 |
) |
|
|
(968 |
) |
Other income (expense) |
|
3 |
|
|
|
(179 |
) |
Total other income (expense) |
|
(2,010 |
) |
|
|
88,500 |
|
Net income ( loss) |
$ |
(26,834 |
) |
|
$ |
64,671 |
|
Net income ( loss) per share, basic |
$ |
(0.34 |
) |
|
$ |
1.03 |
|
Net income ( loss) per share, fully diluted |
$ |
(0.34 |
) |
|
$ |
(0.28 |
) |
Weighted average shares outstanding, basic |
|
79,958,383 |
|
|
|
62,733,080 |
|
Weighted average shares outstanding, fully diluted |
|
79,958,383 |
|
|
|
87,684,818 |
|
1 - Revenue recognized related to the cancellation of a customer contract, resulting in the forfeiture of a customer deposit |
|||||||
2 - The cost of revenue represents costs incurred related to one of the cancelled contracts. |
|||||||
CONDENSED CONSOLIDATED BALANCE SHEETS (in thousands) |
|||||||
|
|
|
|
||||
ASSETS |
|
|
|
||||
Current assets: |
|
|
|
||||
Cash and cash equivalents |
$ |
135,602 |
|
|
$ |
160,036 |
|
Restricted cash, current |
|
100 |
|
|
|
197 |
|
Prepaids and other current assets |
|
7,984 |
|
|
|
9,431 |
|
Total current assets |
|
143,686 |
|
|
|
169,664 |
|
Non-current assets: |
|
|
|
||||
Property, machinery and equipment, net |
|
4,726 |
|
|
|
4,829 |
|
Intangible assets, net |
|
656 |
|
|
|
349 |
|
Operating right-of-use asset |
|
7,282 |
|
|
|
7,604 |
|
Restricted cash, non-current |
|
324 |
|
|
|
314 |
|
Other non-current assets |
|
5,750 |
|
|
|
3,065 |
|
Total assets |
$ |
162,424 |
|
|
$ |
185,825 |
|
|
|
|
|
||||
LIABILITIES AND SHAREHOLDERS’ EQUITY (DEFICIT) |
|
|
|
||||
Current liabilities: |
|
|
|
||||
Accounts payable |
|
3,289 |
|
|
|
1,911 |
|
Accrued expenses |
|
9,568 |
|
|
|
9,785 |
|
Loan payable, current |
|
9,432 |
|
|
|
20,907 |
|
Operating lease liability, current |
|
1,143 |
|
|
|
1,189 |
|
Share repurchase liability, current |
|
6,000 |
|
|
|
— |
|
Other current liabilities |
|
5,090 |
|
|
|
5,075 |
|
Total current liabilities |
|
34,522 |
|
|
|
38,867 |
|
Contract liabilities, non-current |
|
1,654 |
|
|
|
1,554 |
|
Loan Payable, non-current |
|
11,303 |
|
|
|
— |
|
Warrant liability |
|
6,200 |
|
|
|
5,749 |
|
Operating lease liability, non-current |
|
7,002 |
|
|
|
7,284 |
|
Other non-current liabilities |
|
488 |
|
|
|
483 |
|
Total non-current liabilities |
|
26,647 |
|
|
|
15,070 |
|
Total liabilities |
|
61,169 |
|
|
|
53,937 |
|
|
|
|
|
||||
Shareholders’ equity (deficit): |
|
|
|
||||
Common stock, |
|
1 |
|
|
|
1 |
|
Additional paid-in capital |
|
336,771 |
|
|
|
340,570 |
|
Accumulated deficit |
|
(235,517 |
) |
|
|
(208,683 |
) |
Total shareholders’ deficit |
|
101,255 |
|
|
|
131,888 |
|
Total Liabilities and Shareholders’ Deficit |
$ |
162,424 |
|
|
$ |
185,825 |
|
CONSOLIDATED STATEMENTS OF CASH FLOWS (in thousands) |
|||||||
|
Three Months Ended
|
||||||
|
|
2022 |
|
|
|
2021 |
|
Cash flows from operating activities: |
|
|
|
||||
Net income (loss) |
$ |
(26,834 |
) |
|
$ |
64,671 |
|
Adjustments to reconcile net income (loss) to net cash used in operating activities: |
|
|
|
||||
Depreciation and amortization |
|
294 |
|
|
|
199 |
|
Amortization of debt discount and issuance costs |
|
742 |
|
|
|
718 |
|
Accrued interest |
|
13 |
|
|
|
— |
|
Increase in fair value of warrants |
|
451 |
|
|
|
(8,083 |
) |
Increase in fair value of SAFE notes |
|
— |
|
|
|
(81,564 |
) |
Impairment of prepaid launch costs |
|
— |
|
|
|
750 |
|
Loss on disposal of fixed and intangible assets |
|
70 |
|
|
|
— |
|
Stock-based compensation expense |
|
2,212 |
|
|
|
5,768 |
|
Changes in operating assets and liabilities: |
|
|
|
||||
Prepaids and other current assets |
|
1,447 |
|
|
|
(9,246 |
) |
Other non-current assets |
|
(2,685 |
) |
|
|
93 |
|
Accounts payable |
|
1,387 |
|
|
|
(97 |
) |
Accrued expenses |
|
(273 |
) |
|
|
5,120 |
|
Other current liabilities |
|
14 |
|
|
|
80 |
|
Contract liabilities |
|
100 |
|
|
|
146 |
|
Lease liabilities and right-of-use assets |
|
(6 |
) |
|
|
245 |
|
Other non-current liabilities |
|
6 |
|
|
|
— |
|
Net cash used in operating activities |
|
(23,062 |
) |
|
|
(21,199 |
) |
|
|
|
|
||||
Cash flows from investing activities: |
|
|
|
||||
Purchase of property, machinery and equipment |
|
(290 |
) |
|
|
(429 |
) |
Purchases of intangible assets |
|
(231 |
) |
|
|
(3 |
) |
Net cash used in investing activities |
|
(521 |
) |
|
|
(431 |
) |
|
|
|
|
||||
Cash flows from financing activities: |
|
|
|
||||
Proceeds from issuance of SAFE notes |
|
— |
|
|
|
30,853 |
|
Proceeds from issuance of loan payable |
|
— |
|
|
|
25,000 |
|
Proceeds from exercise of stock options |
|
48 |
|
|
|
24 |
|
Payment for repurchase of Section 16 Officer common shares for tax coverage exchange |
|
(59 |
) |
|
|
— |
|
Payment of notes payable |
|
(927 |
) |
|
|
— |
|
Payment of debt issuance costs |
|
— |
|
|
|
(144 |
) |
Payment of warrant issuance costs |
|
— |
|
|
|
(31 |
) |
Net cash provided by financing activities |
|
(938 |
) |
|
|
55,702 |
|
|
|
|
|
||||
Increase in cash and cash equivalents |
|
(24,521 |
) |
|
|
34,071 |
|
Cash and cash equivalents, beginning of period |
|
160,547 |
|
|
|
23,520 |
|
Cash and cash equivalents, end of period |
$ |
136,026 |
|
|
$ |
57,591 |
|
|
|
|
|
||||
Supplemental disclosure of non-cash investing and financing activities |
|
|
|
||||
Deferred offering costs in accounts payable and accrued expenses at period end |
$ |
— |
|
|
$ |
861 |
|
Operating lease right-of-use assets in exchange for lease obligations |
$ |
— |
|
|
$ |
8,501 |
|
Share repurchase liability fair value |
$ |
6,000 |
|
|
$ |
— |
|
|
|
|
|
||||
Supplemental disclosure of cash flow information |
|
|
|
||||
Cash paid for interest |
$ |
750 |
|
|
$ |
250 |
|
Reclassifications
Certain reclassifications have been made to the prior year’s financial statements to conform to the current year’s presentation. None of the reclassifications have changed the total assets, liabilities, shareholders’ deficit, income, expenses or net losses previously reported.
Use of Non-GAAP Financial Measures (unaudited)
This press release references certain non-GAAP financial measures, including adjusted EBITDA, non-GAAP selling, general, and administrative expense and non-GAAP research and development expense. The Company defines adjusted EBITDA as earnings before interest expense, taxes, depreciation and amortization, stock-based compensation, and certain other items the Company believes are not indicative of its core operating performance. The Company defines non-GAAP selling, general, and administrative expenses and research and development expenses as those respective GAAP amounts, excluding stock-based compensation and non-recurring items not indicative of core operating performance None of these non-GAAP financial measures is a substitute for or superior to measures of financial performance prepared in accordance with generally accepted accounting principles in
The Company believes that presenting these non-GAAP financial measures provides useful supplemental information to investors about the Company that is helpful in understanding and evaluating its operating results, enhancing the overall understanding of its past performance and future prospects, and allowing for greater transparency with respect to key financial metrics used by its management in financial and operational-decision making. However, there are a number of limitations related to the use of non-GAAP measures and their nearest GAAP equivalents. For example, other companies may calculate non-GAAP measures differently, or may use other measures to calculate their financial performance, and therefore any non-GAAP measures the Company uses may not be directly comparable to similarly titled measures of other companies.
Quarterly adjusted EBITDA
A reconciliation of adjusted EBITDA to net loss for the three months ended
|
Three Months Ended |
||||||||||
(in thousands) |
|
|
|
|
|
||||||
Net Income (Loss) |
$ |
(26,836 |
) |
|
$ |
64,671 |
|
|
$ |
(2,729 |
) |
Income tax expense |
|
— |
|
|
|
— |
|
|
|
1 |
|
Interest income |
|
— |
|
|
|
(1 |
) |
|
|
— |
|
Interest expense |
|
1,492 |
|
|
|
968 |
|
|
|
5,544 |
|
Depreciation & amortization |
|
294 |
|
|
|
199 |
|
|
|
324 |
|
EBITDA |
|
(25,049 |
) |
|
|
65,837 |
|
|
|
3,140 |
|
(Decrease) increase in fair value of SAFE notes |
|
— |
|
|
|
(81,564 |
) |
|
|
— |
|
(Decrease) increase in fair value of warrants |
|
451 |
|
|
|
(8,083 |
) |
|
|
(27,505 |
) |
Realized loss on disposal of assets |
|
70 |
|
|
|
— |
|
|
|
17 |
|
Investment banking fees related to SAFE financing |
|
— |
|
|
|
178 |
|
|
|
— |
|
Prepaid launch deposit impairment |
|
— |
|
|
|
750 |
|
|
|
— |
|
|
|
795 |
|
|
|
3,873 |
|
|
|
464 |
|
Reduction in |
|
— |
|
|
|
— |
|
|
|
(2,551 |
) |
Class action litigation legal expenses |
|
795 |
|
|
|
— |
|
|
|
797 |
|
Other non-recurring legal expenses |
|
114 |
|
|
|
— |
|
|
|
— |
|
|
|
2,135 |
|
|
|
— |
|
|
|
1,073 |
|
|
|
978 |
|
|
|
— |
|
|
|
905 |
|
Severance and other related expenses1 |
|
350 |
|
|
|
— |
|
|
|
(13 |
) |
Stock-based compensation |
|
2,212 |
|
|
|
5,768 |
|
|
|
7,265 |
|
Adjusted EBITDA |
$ |
(17,149 |
) |
|
$ |
(13,240 |
) |
|
$ |
(16,407 |
) |
1 - Loss contingencies for certain severance agreements were reversed when the Company determined they would not be signed and paid |
|||||||||||
A reconciliation of selling, general, and administrative expenses to non-GAAP selling, general, and administrative expenses for the three months ended
|
Three Months Ended |
||||||||
(in thousands) |
|
|
|
|
|
||||
Selling, general, and administrative expenses |
$ |
14,853 |
|
$ |
14,005 |
|
$ |
13,103 |
|
Stock-based compensation |
|
1,839 |
|
|
5,700 |
|
|
5,109 |
|
|
|
795 |
|
|
3,873 |
|
|
464 |
|
Reduction in |
|
— |
|
|
— |
|
|
(2,551 |
) |
Class action litigation legal expenses |
|
795 |
|
|
— |
|
|
797 |
|
Other non-recurring legal expenses |
|
114 |
|
|
— |
|
|
— |
|
|
|
2,135 |
|
|
— |
|
|
1,073 |
|
|
|
978 |
|
|
— |
|
|
905 |
|
Severance and other related expenses1 |
|
— |
|
|
— |
|
|
(13 |
) |
Non-GAAP selling, general, administration expenses |
$ |
8,197 |
|
$ |
4,432 |
|
$ |
7,318 |
|
1 - Loss contingencies for certain severance agreements were reversed when the Company determined they would not be signed and paid |
|||||||||
A reconciliation of research and development expenses to non-GAAP research and development expenses for the three months ended
|
Three Months Ended |
|||||||
(in thousands) |
|
|
|
|
|
|||
Research and development expenses |
$ |
9,971 |
|
$ |
9,906 |
|
$ |
11,574 |
Prepaid launch deposit impairment |
|
— |
|
|
750 |
|
|
— |
Stock-based compensation |
|
373 |
|
|
68 |
|
|
2,156 |
Severance and other related expenses |
|
350 |
|
|
— |
|
|
— |
|
$ |
9,248 |
|
$ |
9,088 |
|
$ |
9,418 |
View source version on businesswire.com: https://www.businesswire.com/news/home/20220510006388/en/
For media inquiries:
For investor relations inquiries:
Source:
FAQ
What were Momentus Inc.'s Q1 2022 financial results?
What is the launch schedule for Vigoride from Momentus?
What agreements has Momentus signed for future launches?
What regulatory approvals has Momentus obtained?